Nimbus Therapeutics

Nimbus TherapeuticsNimbus Therapeutics
Nimbus Therapeutics

Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.

Website
DR 55Speed 672009ActiveBoston, United States
Rate
Advertise here

About

Nimbus Therapeutics is a clinical-stage biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine. They focus on precision small molecule design for targets implicated in multiple human diseases, including oncology, immunology, and metabolic disorders. Their approach combines cutting-edge computational chemistry, structural biology, and machine learning to accelerate the drug discovery and development process.
Frequently asked

What does Nimbus Therapeutics do?

Nimbus Therapeutics is a clinical-stage biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine. They focus on precision small molecule design for targets implicated in multiple human diseases, including oncology, immunology, and metabolic disorders. Their approach combines cutting-edge computational chemistry, structural biology, and machine learning to accelerate the drug discovery and development process.

What is Nimbus Therapeutics's revenue?

StartupHub estimates Nimbus Therapeutics's annual revenue at $34.6M (range $14.3M to $172.1M, 33% confidence), based on comparable companies in the sector.

What is Nimbus Therapeutics's valuation?

StartupHub estimates Nimbus Therapeutics's effective valuation at $2.4B (range $1.5B to $3.5B, 12% confidence), based on comparable companies in the sector.

How much funding has Nimbus Therapeutics raised?

Nimbus Therapeutics has raised a total of $589M in funding. The most recent round on record is Series F.

Where is Nimbus Therapeutics headquartered?

Nimbus Therapeutics is headquartered in Boston, United States.

When was Nimbus Therapeutics founded?

Nimbus Therapeutics was founded in 2009.

What industry does Nimbus Therapeutics operate in?

Nimbus Therapeutics operates in Biotechnology, Drug Discovery, AI, Machine Learning, Small Molecule Therapeutics.

New entrants in Biotechnology
Last 90 days
7
New entrants
2.3
Per month
0.5
Per week
Most recent
Galatek

Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.

Jul 13
Raven4batchrecords

Digital batch record software for pharmaceutical and biotech manufacturing.

Jul 9
Trofinetide

Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.

Jun 8
Nanorobotics

A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.

May 28
Matrixcode

MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.

May 27
Cypherpunkcode

A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.

May 26

An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.